Introduced October 24, 2025 by Thomas Massie · Last progress October 24, 2025
The bill substantially strengthens property and enforcement rights for patent holders and improves USPTO funding predictability, but does so at the cost of reduced administrative patent review, higher litigation risk and costs, greater uncertainty during transition, and likely higher prices and barriers for competitors, consumers, researchers, and some small businesses.
Patent owners (inventors, small businesses, and assignees) will gain stronger, more enforceable property rights — including a reinforced presumption of validity, tolling of patent term during challenges, easier injunctive relief, and limits on administrative cancellations — making patents more valuable and easier to monetize.
Inventors and small businesses regain earlier statutory regimes (pre‑AIA first‑to‑invent rules and a one‑year disclosure grace period), which can protect prior work and make public disclosures safer for attracting investors or testing markets.
Researchers, biotech and software innovators will be more able to obtain patents because subject‑matter eligibility is expanded, reducing rejections based on prior restrictive doctrines and potentially increasing startup financing and R&D investment.
Consumers, patients, and downstream businesses face higher costs and reduced competition because extended and strengthened patent monopolies (tolling terms, stronger validity/injunction presumptions, and limits on administrative cancellations) make it harder and slower to clear patents or enter markets.
Small businesses, startups, and implementers will lose fast, lower‑cost administrative routes (IPR/PGR/inter partes reviews) for invalidating weak patents, shifting disputes to costlier and slower district‑court litigation and appeals.
Accused infringers and challengers will face higher litigation risk and a chilling effect on legitimate challenges because of increased burdens of proof (clear-and-convincing standards), potential bad‑faith damages, and presumptions favoring patentees.
Based on analysis of 24 sections of legislative text.
Changes to patent law that greatly strengthen issued patents and shift many disputes back to federal courts. The bill stops automatic 18‑month publication of patent applications, restores a first‑to‑invent standard and pre‑AIA one‑year grace period, abolishes administrative post‑grant challenges (IPR/PGR) and the PTAB, and makes courts more likely to find patents valid and to order injunctions. It also narrows what is excluded from patenting, rewrites novelty rules, creates a USPTO revolving fee fund, and declares that patents are private property revocable only by a court.